- Superior support for aging joints
- Next-generation, multi-nutrient formula
- AprèsFlex® boswellia inhibits 5-LOX enzyme
- UC-II® standardized chicken cartilage extract supports joint comfort and ease of motion
- AprèsFlex® absorbs much better than traditional boswellia
ArthroMax Advanced (60 capsules)
$29.95 USD
Description
Many people overlook the important role that optimized nutrition can play in joint health and comfortable movement. And ArthroMax® Advanced with UC-II® & AprèsFlex® contains multiple nutrients to provide more joint support than ever before. The key to this advanced formula lies with two of its nutrients: AprèsFlex® and UC-II®. AprèsFlex® boswellia is a superior inhibitor of 5-LOX (5-lipoxygenase enzyme), and UC-II® promotes ease of motion. Choose the one joint health supplement developed from the ground up to ease your range of motion and support joint health. Try ArthroMax® Advanced with UC-II® & AprèsFlex® and today!
Suggested Use:
Take two (2) capsules daily with food, or as recommended by a healthcare practitioner.
Ingredients:
| Serving Size 2 capsules | |
| Servings Per Container 30 | |
| Amount Per Serving | |
| Glucosamine sulfate 2KCI (derived from corn) | 1500 mg |
| AprèsFlex® Indian frankincense (Boswellia serrata) extract (gum resin) [std. to 20% AKBAΔ (20 mg)] | 100 mg |
| UC-II® standardized cartilage | 40 mg |
| Total Collagen | 10 mg |
| Boron (calcium fructoborate as patented FruiteX B® OsteoBoron®) | 1.5 mg |
| Other ingredients: vegetable cellulose (capsule), potassium chloride, microcrystalline cellulose, vegetable stearate, silica. | |
Non-GMO
Δ3-O-acetyl-11-keto-ß-boswellic acid
UC-II® is a registered trademark of InterHealth N.I. (U.S. Patents 7,846,487, 7,083,820 and EPO Patent EP1435906B1; Canadian Patent CA 2459981C; and Japanese Patent JP 4800574B2).
AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila NUTRA LLC. U.S. Patent No. 8,551,496 and other patents pending.
FruitX B® and OsteoBoron® are registered trademarks of VDF FutureCeuticals, Inc. U.S. Patent No. 5,962,049.
You must be logged in to post a review.
Reviews
There are no reviews yet.